Filtros de búsqueda

Lista de obras de

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

artículo científico publicado en 2016

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

artículo científico publicado en 2015

Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model

artículo científico publicado en 2017

Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

artículo científico publicado en 2015

High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection

artículo científico publicado en 2008

IL-15 stimulation with TIGIT blockade reverses CD155-mediated NK cell dysfunction in melanoma

artículo científico publicado en 2020

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts.

artículo científico publicado en 2017

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

artículo científico publicado en 2016

Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers

scientific article published on 26 November 2019

TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM.

artículo científico publicado en 2018

TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer

scientific article published on 08 November 2020

Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy

article

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda